Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus

Neuroscience

Volumn 162, Issue 4, 2009, Pages 1411-1419

  Cooke, J D ^a   Grover, L M ^a   Spangler, P R ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressant; CA1; glutamate; long term potentiation; neurotrophin; synaptic transmission

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN SLICE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FRONTAL CORTEX; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC TRANSMISSION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLOHEXANOLS; FRONTAL LOBE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 67949109533     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.05.037     Document Type: Article

References (77)

1. Altar C.A., Whitehead R.E., Chen R., Wörtwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54 (2003) 703-709
2. Artigas F., Nutt D.J., and Shelton R. Mechanism of action of antidepressants. Psychopharmacol Bull 36 Suppl 2 (2002) 123-132
3. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 261-265
4. Balkowiec A., and Katz D.M. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci 22 (2002) 10399-10407
5. Balu D.T., Hoshaw B.A., Malberg J.E., Rosenzweig-Lipson S., Schechter L.E., and Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res 1211 (2008) 37-43
6. Bartesaghi R. Effect of early isolation on the synaptic function in the dentate gyrus and field CA1 of the guinea pig. Hippocampus 14 (2004) 482-498
7. Belmaker R.H., and Agam G. Major depressive disorder. N Engl J Med 358 (2008) 55-68
8. Berger M., and Gastpar M. Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci 246 (1996) 235-239
9. Beyer C.E., Boikess S., Luo B., and Dawson L.A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol 16 (2002) 297-304
10. Bezchlibnyk-Butler K., Aleksic I., and Kennedy S.H. Citalopram-a review of pharmacological and clinical effects. J Psychiatry Neurosci 25 (2000) 241-254
11. Birnstiel S., and Haas H.L. Acute effects of antidepressant drugs on long-term potentiation (LTP) in rat hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 344 (1991) 79-83
12. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
13. Calabrese F., Molteni R., Maj P.F., Cattaneo A., Gennarelli M., Racagni G., and Riva M.A. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32 (2007) 2351-2359
14. Castrén E., Pitkänen M., Sirviö J., Parsadanian A., Lindholm D., Thoenen H., and Riekkinen P.J. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus. Neuroreport 4 (1993) 895-898
15. Castrén E., Võikar V., and Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7 (2007) 18-21
16. David D.J.P., Bourin M., Jego G., Przybylski C., Jolliet P., and Gardier A.M. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 140 (2003) 1128-1136
17. Dawson L.A., Nguyen H.Q., and Geiger A. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Neuropharmacology 38 (1999) 1153-1163
18. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., and Zetterström T.S.C. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
19. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
20. Dragunow M., Beilharz E., Mason B., Lawlor P., Abraham W., and Gluckman P. Brain-derived neurotrophic factor expression after long-term potentiation. Neurosci Lett 160 (1993) 232-236
21. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry 7 Suppl 1 (2002) S29-S34
22. Feighner J.P. Mechanism of action of antidepressant medications. J Clin Psychiatry 60 Suppl 4 (1999) 4-11 discussion: 12-13
23. Felton T.M., Kang T.B., Hjorth S., and Auerbach S.B. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 297-305
24. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., and Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381 (1996) 706-709
25. Fone K.C.F., and Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 32 (2008) 1087-1102
26. Gärtner A., and Staiger V. Neurotrophin secretion from hippocampal neurons evoked by long-term-potentiation-inducing electrical stimulation patterns. Proc Natl Acad Sci U S A 99 (2002) 6386-6391
27. Gervasoni N., Aubry J., Bondolfi G., Osiek C., Schwald M., Bertschy G., and Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
28. Gillman P.K. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151 (2007) 737-748
29. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., and Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255 (2005) 381-386
30. Gottschalk W.A., Jiang H., Tartaglia N., Feng L., Figurov A., and Lu B. Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn Mem 6 (1999) 243-256
31. Gur E., Dremencov E., Lerer B., and Newman M.E. Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 372 (1999) 17-24
32. Hartmann M., Heumann R., and Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20 (2001) 5887-5897
33. Hatanaka K., Yatsugi S., and Yamaguchi T. Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex. Eur J Pharmacol 395 (2000) 31-36
34. Hatanaka K., Yatsugi S., and Yamaguchi T. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex. Eur J Pharmacol 395 (2000) 23-29
35. Jacobsen J.P.R., and Mørk A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 1024 (2004) 183-192
36. Johnston D., Williams S., Jaffe D., and Gray R. NMDA-receptor-independent long-term potentiation. Annu Rev Physiol 54 (1992) 489-505
37. Kang H., and Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267 (1995) 1658-1662
38. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J., and Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57 (2005) 1068-1072
39. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 (2002) 143-148
40. Katoh-Semba R., Takeuchi I.K., Semba R., and Kato K. Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 69 (1997) 34-42
41. Koch S., Hemrick-Luecke S.K., Thompson L.K., Evans D.C., Threlkeld P.G., Nelson D.L., Perry K.W., and Bymaster F.P. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Neuropharmacology 45 (2003) 935-944
42. Kojima T., Matsumoto M., Togashi H., Tachibana K., Kemmotsu O., and Yoshioka M. Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors. Brain Res 959 (2003) 165-168
43. Kozisek M.E., Middlemas D., and Bylund D.B. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117 (2008) 30-51
44. Langosch J.M., and Walden J. Effects of the atypical antidepressant trimipramine on neuronal excitability and long-term potentiation in guinea pig hippocampal slices. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 299-302
45. Larsen M.H., Hay-Schmidt A., Rønn L.C.B., and Mikkelsen J.D. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol 578 (2008) 114-122
46. Levine E.S., Dreyfus C.F., Black I.B., and Plummer M.R. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci U S A 92 (1995) 8074-8077
47. Lynch M.A. Long-term potentiation and memory. Physiol Rev 84 (2004) 87-136
48. Mannari C., Origlia N., Scatena A., Del Debbio A., Catena M., Dell'agnello G., Barraco A., Giovannini L., Dell'osso L., Domenici L., and Piccinni A. BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 28 (2008) 457-468
49. Massicotte G., Bernard J., and Ohayon M. Chronic effects of trimipramine, an antidepressant, on hippocampal synaptic plasticity. Behav Neural Biol 59 (1993) 100-106
50. Mnie-Filali O., El Mansari M., Espana A., Sànchez C., and Haddjeri N. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Neurosci Lett 395 (2006) 23-27
51. Nawa H., Carnahan J., and Gall C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur J Neurosci 7 (1995) 1527-1535
52. Nemeroff C.B., Entsuah R., Benattia I., Demitrack M., Sloan D.M., and Thase M.E. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry 63 (2008) 424-434
53. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
54. Ohashi S., Matsumoto M., Otani H., Mori K., Togashi H., Ueno K., Kaku A., and Yoshioka M. Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine. Brain Res 949 (2002) 131-138
55. Ohashi S., Togashi H., Matsumoto M., Mori K., Ueno K., and Yoshioka M. Changes in synaptic properties in cortical-limbic communications induced by repeated treatments with fluvoxamine in rats. J Pharmacol Sci 92 (2003) 100-107
56. Okuyama S., and Aihara H. Effect of minaprine on electrical activity of the rat hippocampus in vivo. Naunyn Schmiedebergs Arch Pharmacol 340 (1989) 1-5
57. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 (1996) 1137-1145
58. Patterson S.L., Grover L.M., Schwartzkroin P.A., and Bothwell M. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 9 (1992) 1081-1088
59. Piacentini M.F., Clinckers R., Meeusen R., Sarre S., Ebinger G., and Michotte Y. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo. Life Sci 73 (2003) 2433-2442
60. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., Mannari C., Martini C., Da Pozzo E., Schiavi E., Mariotti A., Roncaglia I., Palla A., Consoli G., Giovannini L., Massimetti G., and Dell'Osso L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105 (2008) 279-283
61. Randrup A., and Braestrup C. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology (Berl) 53 (1977) 309-314
62. Richelson E., and Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104 (1984) 277-286
63. Rizzi S., Bianchi P., Guidi S., Ciani E., and Bartesaghi R. Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. Hippocampus 17 (2007) 78-91
64. Russo-Neustadt A.A., Alejandre H., Garcia C., Ivy A.S., and Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29 (2004) 2189-2199
65. Scaccianoce S., Del Bianco P., Paolone G., Caprioli D., Modafferi A.M.E., Nencini P., and Badiani A. Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone. Behav Brain Res 168 (2006) 323-325
66. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., and Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
67. Smith D., Dempster C., Glanville J., Freemantle N., and Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 180 (2002) 396-404
68. Stewart C.A., and Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl) 148 (2000) 217-223
69. Tachibana K., Matsumoto M., Koseki H., Togashi H., Kojima T., Morimoto Y., and Yoshioka M. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems. J Psychopharmacol 20 (2006) 562-569
70. Tachibana K., Matsumoto M., Togashi H., Kojima T., Morimoto Y., Kemmotsu O., and Yoshioka M. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors. Neurosci Lett 357 (2004) 91-94
71. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58 (2006) 115-134
72. Thase M.E., Entsuah A.R., and Rudolph R.L. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178 (2001) 234-241
73. Vouimba R., Muñoz C., and Diamond D.M. Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 9 (2006) 29-40
74. Wang J., David D.J., Monckton J.E., Battaglia F., and Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28 (2008) 1374-1384
75. Weikop P., Kehr J., and Scheel-Krüger J. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus. J Psychopharmacol 18 (2004) 395-403
76. White K.J., Walline C.C., and Barker E.L. Serotonin transporters: implications for antidepressant drug development. AAPS J 7 (2005) E421-E433
77. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., Ueda N., and Nakamura J. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1034-1037